| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |